Funding Rounds
Aphea.Bio

Aphea.Bio Series C (2023, $76M)

Aphea.Bio

Developing next generation ‘biopesticides’ based on natural microorganisms.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series C

Raised Amount: $76.90M

Raised Date: 2023-12-01

Investors